← Back to Search

Continuous Glucose Monitoring

Dexcom CGM for Diabetes

N/A

Recruiting

Led By Elizabeth Buschur, MD

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial will test whether using a continuous glucose monitor can help manage diabetes in pregnant and postpartum women during hospitalizations, potentially reducing the number of point of care glucose tests needed, staff exposure, and PPE use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Maternal outcomes

Neonatal outcomes

Side effects data

From 2020 Phase 4 trial • 10 Patients • NCT03670641

70%

Hypoglycemia

60%

Signal Loss with Continuous Glucose Monitor (CGM)

100%

80%

60%

40%

20%

Study treatment Arm

Insulin and CGM Intervention

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dexcom CGMExperimental Treatment1 Intervention

Proof of concept randomized study to evaluate the utility of Dexcom-G6 continuous glucose monitors for assessment of glycemic control in pregnant and postpartum women with insulin-requiring diabetes mellitus during hospitalizations

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Dexcom G6

2020

Completed Phase 4

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor

828 Previous Clinical Trials

505,711 Total Patients Enrolled

5 Trials studying Diabetes

272 Patients Enrolled for Diabetes

DexCom, Inc.Industry Sponsor

137 Previous Clinical Trials

29,810 Total Patients Enrolled

15 Trials studying Diabetes

3,728 Patients Enrolled for Diabetes

Elizabeth Buschur, MDPrincipal InvestigatorOhio State University

2 Previous Clinical Trials

112 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people aged 45 or under qualified to participate in this experiment?

"This trial is open to adults aged 18-50."

Answered by AI

Are there new enrollments available for this clinical experiment?

"All signs point to this clinical trial actively seeking participants. The research was initially uploaded on May 15th, 2022 and last modified on July 26th of the same year."

Answered by AI

How many volunteers are being accepted for participation in this research?

"Affirmative. Clinicaltrials.gov indicates that recruitment for this trial is currently ongoing, which was first advertised on May 15th 2022 and last updated July 26th 2022. 40 participants are needed to be enrolled at a single site."

Answered by AI

Does this research initiative allow volunteers to join?

"This clinical trial is searching for 40 people who have diabetes mellitus and are aged between 18 and 50. To be eligible, women must possess the following: singleton or twin intrauterine pregnancy of 8 0/7 to 41 6/7 weeks gestation as evaluated by ACOG criteria; pre-gestational or gestational diabetes A2 diagnosis; hospital admission during labor or other antepartum admissions excluding DKA and glucoregulation issues; comprehension of the study's purpose with consent given in English language written format. Finally, infants surviving up until discharge from medical care whose mothers participated in this trial will also qualify."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Continuous Glucose Monitoring for Personal Protective Equipment Evaluation

2022. "Continuous Glucose Monitoring for Personal Protective Equipment Evaluation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05478070.